D. Dahms - Dec 21, 2021 Form 4 Insider Report for Theseus Pharmaceuticals, Inc. (THRX)

Role: Chief Financial Officer
Signature: /s/ Bradford Dahms
Stock symbol: THRX
Transactions as of: Dec 21, 2021
Transactions value $: $20,000
Form type: 4
Date filed: 12/22/2021, 05:21 PM
Previous filing: Oct 6, 2021
Next filing: Feb 23, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	THRX	Common Stock	Purchase	$20K	+1.97K		$10.15	1.97K	Dec 21, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transaction at prices ranging from $10.09 to $10.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Content

The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transaction at prices ranging from $10.09 to $10.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.